HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Andrew J Ullmann Selected Research

posaconazole

12/2017Pharmacokinetics and safety results from the Phase 3 randomized, open-label, study of intravenous posaconazole in patients at risk of invasive fungal disease.
12/2017Pharmacokinetics and safety results from the Phase 3 randomized, open-label, study of intravenous posaconazole in patients at risk of invasive fungal disease.
9/2014Primary prophylaxis of invasive fungal infections in patients with haematologic malignancies. 2014 update of the recommendations of the Infectious Diseases Working Party of the German Society for Haematology and Oncology.
7/2014Phase 1B study of the pharmacokinetics and safety of posaconazole intravenous solution in patients at risk for invasive fungal disease.
12/2009Impact of antifungal prophylaxis on colonization and azole susceptibility of Candida species.
2/2009Treatment of invasive fungal infections in cancer patients--recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO).
1/2009Primary prophylaxis of invasive fungal infections in patients with hematologic malignancies. Recommendations of the Infectious Diseases Working Party of the German Society for Haematology and Oncology.
5/2008Numbers needed to treat with posaconazole prophylaxis to prevent invasive fungal infection and death.
2/2008Broad-spectrum antifungal prophylaxis in patients with cancer at high risk for invasive mold infections: point.
12/2007Pharmacokinetics of oral posaconazole in allogeneic hematopoietic stem cell transplant recipients with graft-versus-host disease.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Andrew J Ullmann Research Topics

Disease

21Invasive Fungal Infections
02/2020 - 05/2003
18Mycoses (Diseases, Fungus)
11/2018 - 05/2003
15Infections
10/2020 - 10/2003
14Aspergillosis
08/2018 - 10/2003
11Neoplasms (Cancer)
11/2018 - 05/2003
11Neutropenia
02/2018 - 05/2003
10Graft vs Host Disease (Graft-Versus-Host Disease)
09/2014 - 05/2003
6Myelodysplastic Syndromes (Myelodysplastic Syndrome)
02/2018 - 01/2007
5Candidiasis (Moniliasis)
08/2016 - 10/2003
5Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
04/2015 - 12/2006
3Hematologic Neoplasms (Hematological Malignancy)
07/2022 - 05/2005
3Communicable Diseases (Infectious Diseases)
09/2016 - 10/2003
3Invasive Candidiasis
02/2014 - 02/2008
3Fever (Fevers)
03/2011 - 05/2004
2Vomiting
12/2017 - 03/2011
2Fever of Unknown Origin
08/2016 - 03/2008
2Diarrhea
03/2011 - 12/2007
2Nausea
03/2011 - 02/2006
2Invasive Pulmonary Aspergillosis
01/2009 - 11/2007
2Leukemia
02/2008 - 09/2003
2Febrile Neutropenia
06/2006 - 01/2004
1Mucormycosis
01/2018
1Edema (Dropsy)
12/2017
1Atrial Fibrillation
12/2017
1Critical Illness (Critically Ill)
06/2017
1Bacteriuria
06/2017
1Respiratory Tract Infections (Respiratory Tract Infection)
06/2017
1Eye Diseases (Eye Disease)
02/2016
1Digestive System Diseases
02/2016
1Gastrointestinal Diseases (Functional Gastrointestinal Disorders)
02/2016
1Phlebitis
03/2011
1Hypokalemia
03/2011
1Pneumococcal Infections
05/2009
1Body Weight (Weight, Body)
12/2007
1Pulmonary Aspergillosis
11/2007
1Hematologic Diseases (Blood Diseases)
12/2006
1Residual Neoplasm
10/2005
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
10/2005
1Toxoplasmosis
01/2005
1Disease Progression
10/2004

Drug/Important Bio-Agent (IBA)

15posaconazoleFDA Link
12/2017 - 06/2006
10Voriconazole (Vfend)FDA LinkGeneric
02/2018 - 01/2003
10Fluconazole (Zonal)FDA LinkGeneric
09/2014 - 10/2003
7Biomarkers (Surrogate Marker)IBA
10/2020 - 01/2017
7Amphotericin B (Amphotericin)FDA LinkGeneric
01/2020 - 05/2003
7Caspofungin (Cancidas)FDA Link
08/2016 - 10/2003
7liposomal amphotericin BFDA Link
09/2014 - 12/2006
6Itraconazole (Sporanox)FDA LinkGeneric
08/2016 - 02/2006
5Micafungin (FK463)FDA Link
02/2014 - 11/2006
4Pharmaceutical PreparationsIBA
09/2014 - 02/2006
3Sodium Glutamate (Accent)IBA
11/2018 - 03/2008
3LipidsIBA
08/2016 - 12/2006
3Adrenal Cortex Hormones (Corticosteroids)IBA
02/2014 - 05/2003
3PolyenesIBA
12/2006 - 05/2003
2CytokinesIBA
01/2018 - 10/2003
2letermovirIBA
12/2017 - 05/2014
2DNA (Deoxyribonucleic Acid)IBA
12/2017 - 01/2005
2Anti-Bacterial Agents (Antibiotics)IBA
06/2017 - 04/2008
2isavuconazoleIBA
02/2016 - 04/2015
2SolutionsIBA
07/2014 - 02/2006
2Antifungal AgentsIBA
04/2008 - 11/2006
2Alemtuzumab (Campath)FDA Link
01/2007 - 05/2004
2Imatinib Mesylate (Gleevec)FDA Link
10/2005 - 09/2003
1AntigensIBA
10/2020
1Molecular Probes (Molecular Probe)IBA
01/2020
1Gallium-68IBA
01/2020
1SiderophoresIBA
01/2020
1AntibodiesIBA
01/2020
1blue dextranIBA
01/2018
1L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
01/2018
1C-Reactive ProteinIBA
06/2017
1ProcalcitoninIBA
06/2017
1Immunosuppressive Agents (Immunosuppressants)IBA
10/2015
1SteroidsIBA
09/2014
1CyclodextrinsIBA
07/2014
1Alkaline PhosphataseIBA
03/2011
1Aspartate Aminotransferases (Aspartate Transaminase)IBA
03/2011
1Alanine Transaminase (SGPT)IBA
03/2011
1Antineoplastic Agents (Antineoplastics)IBA
11/2009
1EchinocandinsIBA
02/2009
1Cytarabine (Cytosar-U)FDA LinkGeneric
04/2008
1Dexamethasone (Maxidex)FDA LinkGeneric
11/2007
1deoxycholate drug combination amphotericin BIBA
12/2006
1CreatinineIBA
08/2006
1bcr-abl Fusion ProteinsIBA
10/2005
1fludarabineIBA
05/2005
1Melphalan (Alkeran)FDA LinkGeneric
05/2005

Therapy/Procedure

18Therapeutics
02/2018 - 05/2003
13Drug Therapy (Chemotherapy)
02/2018 - 05/2003
11Transplantation
07/2022 - 10/2003
9Stem Cell Transplantation
09/2016 - 09/2003
6Hematopoietic Stem Cell Transplantation
08/2012 - 09/2003
2Remission Induction
02/2018 - 09/2014
2Cell Transplantation
12/2017 - 05/2014
2Aftercare (After-Treatment)
10/2005 - 05/2004
1Chemoprevention
07/2022
1Salvage Therapy
08/2016
1Length of Stay
11/2007
1Induction Chemotherapy
11/2007
1Catheters
05/2007